Drug price controls go nationwide, and Beijing helps hospitals compensate – China politics and current affairs news from May 12, 2017


A summary of today’s top news in Chinese politics and current affairs. Part of the daily SupChina news roundup "China’s Belt and Road: Coming soon to a theater near you."

Caixin reports that “the central government will dole out 20 million yuan ($2.9 million) to each of 338 cities to launch pilot reform programs at their respective public hospitals” — this will offset the losses caused by healthcare reforms that will ban hospitals from marking up drug prices. Last month, the Beijing government became the first in the country to ban the 15 to 20 percent markups common on drugs sold in Chinese hospitals, and the National Health and Family Planning Commission (NHFPC) plans to enforce a similar ban nationwide by September of this year. Caixin notes that the offset program is only on a trial basis, and a NHFPC spokesperson “did not say how long the trial program — and the government funding — will last.”